Clinical Trials Browser

Withdrawn × Bronchiolitis Obliterans Syndrome × Clear all

NCT02743546 2025-02-03

Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT02975921 2019-01-11

Betadine Pleurodesis Via Tunneled Pleural Catheters

Phase 4 Withdrawn

Thoracic

Bronchiolitis Obliterans Syndrome, Pleural Effusion, Pleural Effusion, Malignant

NCT00349518 2016-02-17

Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL

Phase 2/3 Withdrawn

LymphoidMyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01988701 2015-03-02

Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease

Withdrawn

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Hematologic Neoplasms